If you’re a man, should you undergo PSA testing as a screening method for prostate cancer?
As Rick and I discuss on PodMed TT this week, and as we’ve discussed many times over our decade-plus of reporting on the weekly medical news, the answer remains a resounding “maybe.”
That’s according to the latest guidelines from the U.S. Preventive Services Task Force and published this week in JAMA. This august body reviewed the available literature and concluded that certain men, including those with a family history of adenocarcinoma or African ethnicity, perhaps should be screened with a PSA test, while those older than 70 likely should give it a miss.
Yet these guidelines are far from concrete and underline two things: the need for a robust discussion with one’s primary care provider regarding individual risk factors and concerns, and the desperate need for something a good deal better than PSA to identify prostate cancer.
Other topics this week include two from NEJM: Investigational Testing for Zika Virus among U.S. Blood Donors and MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis; and another from JAMA: Crowdfunding for Unproven Stem Cell–Based Interventions.
Until next week, y’all listen up and make healthy choices.